Neeraj Narula, MD, MPH, FRCP(C)
Director of the IBD Clinic
Hamilton Health Sciences
Assistant Professor of Medicine
Talat Bessissow, MD, MSc, FRCP(C)
Associate Professor of Medicine
Division of Gastroenterology
McGill University Health Centre
Sunday, April 3, 2022
7:30 am - 8:15 am
Concurrent Session #4:
Trading Cases: Perspectives on Acute Severe UC
After participating in this session, you will be able to:
- Assess and direct the role and use of steroids in patients presenting with acute severe UC.
- Discuss options for patients with acute severe UC who do not respond to initial treatments.
- Monitor patients with acute severe UC to determine the need and timing for treatment changes.
- 7:30-7:50 am: Case 1: Steroid use, duration, route and assessing response.
- 7:50:8:15 am: Case 2: Approaching the treatment-failure patient presenting with severe UC.
- 8:15-8:30 am: Audience Q&A
Dr. Neeraj Narula is an Associate Professor of Medicine and the Director of the IBD Clinic at McMaster University and a Staff Gastroenterologist at Hamilton Health Sciences. He completed the Present-Levison Advanced IBD fellowship in Mount Sinai Medical Centre in New York, NY, in 2015. He trained to be a Chartered Accountant at the University of Waterloo and has worked at Ernst & Young and KPMG. He subsequently attended medical school at the University of Alberta. He completed internal medicine residency and gastroenterology fellowship training at McMaster University. He also obtained a Masters in Public Health at Harvard TH Chan School of Public Health. His research interests are predominantly in clinical epidemiology, nutrition, and pharmaceutical trials in IBD. He has over 90 peer-reviewed publications in the field of IBD and authored 4 textbook chapters.
Dr. Talat Bessissow earned his medical degree at McGill University (2005) where he then completed post-graduate training in Internal Medicine and Gastroenterology (2005-2010). In 2012, he trained in inflammatory bowel disease and advanced endoscopic imaging at the Gasthuisberg University Hospital, Leuven, Belgium under the supervision of professor Severine Vermeire. He also competed a Master in experimental medicine and epidemiology from McGill University in 2016. Since 2012, He is a full time Associate Professor to the Division of Gastroenterology and Attending Staff at the McGill University Health Center. He is member of the McGill IBD group as well as the McGill small bowel program. His current research focuses on the role and outcomes of mucosal healing in inflammatory bowel disease as well as early detection of neoplastic lesions in ulcerative colitis. His researched has led him publish over 70 peer-reviewed full papers. He is the vice-president of the Canadian IBD Research Consortium. He has also served as a review for multiple national and international journal and is currently an associate editorial of the Journal of the Canadian Association of Gastroenterology.